- Home
- MQ vs CNTA Comparison
MQ vs CNTA Comparison
Compare MQ & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQ
- CNTA
- Stock Information
- Founded
- MQ 2010
- CNTA 2020
- Country
- MQ United States
- CNTA United Kingdom
- Employees
- MQ N/A
- CNTA N/A
- Industry
- MQ Computer Software: Prepackaged Software
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- MQ Technology
- CNTA Health Care
- Exchange
- MQ Nasdaq
- CNTA Nasdaq
- Market Cap
- MQ 1.9B
- CNTA 1.9B
- IPO Year
- MQ 2021
- CNTA 2021
- Fundamental
- Price
- MQ $5.77
- CNTA $15.69
- Analyst Decision
- MQ Hold
- CNTA Strong Buy
- Analyst Count
- MQ 13
- CNTA 10
- Target Price
- MQ $5.35
- CNTA $28.78
- AVG Volume (30 Days)
- MQ 5.8M
- CNTA 984.4K
- Earning Date
- MQ 08-06-2025
- CNTA 08-12-2025
- Dividend Yield
- MQ N/A
- CNTA N/A
- EPS Growth
- MQ N/A
- CNTA N/A
- EPS
- MQ 0.11
- CNTA N/A
- Revenue
- MQ $528,100,000.00
- CNTA $15,000,000.00
- Revenue This Year
- MQ $18.09
- CNTA N/A
- Revenue Next Year
- MQ $21.72
- CNTA N/A
- P/E Ratio
- MQ $53.77
- CNTA N/A
- Revenue Growth
- MQ N/A
- CNTA 118.88
- 52 Week Low
- MQ $3.37
- CNTA $9.00
- 52 Week High
- MQ $6.01
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- MQ 59.96
- CNTA 68.00
- Support Level
- MQ $5.70
- CNTA $13.22
- Resistance Level
- MQ $6.01
- CNTA $15.48
- Average True Range (ATR)
- MQ 0.13
- CNTA 0.70
- MACD
- MQ -0.03
- CNTA 0.21
- Stochastic Oscillator
- MQ 58.73
- CNTA 86.44
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.